Overview

A Study to Evaluate Retisert in the Treatment of Patients With the "Wet" Form of Age-Related Macular Degeneration

Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
A study evaluating Retisert in patients with age-related macular degeneration
Phase:
Phase 2
Details
Lead Sponsor:
Control Delivery Systems
Collaborator:
Bausch & Lomb Incorporated
Treatments:
Fluocinolone Acetonide